BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21122718)

  • 21. Health care use and health and functional impact of developmental disabilities among US children, 1997-2005.
    Boulet SL; Boyle CA; Schieve LA
    Arch Pediatr Adolesc Med; 2009 Jan; 163(1):19-26. PubMed ID: 19124699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivors of extracorporeal membrane oxygenation at 1 year of age: the relationship of primary diagnosis with health and neurodevelopmental sequelae.
    Bernbaum J; Schwartz IP; Gerdes M; D'Agostino JA; Coburn CE; Polin RA
    Pediatrics; 1995 Nov; 96(5 Pt 1):907-13. PubMed ID: 7478834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future.
    van Karnebeek CD; Bowden K; Berry-Kravis E
    Pediatr Neurol; 2016 Dec; 65():1-13. PubMed ID: 27697313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimizing health risks among older adults with intellectual and/or developmental disabilities: clinical considerations to promote quality of life.
    Hahn JE
    J Gerontol Nurs; 2012 Jun; 38(6):11-7. PubMed ID: 22587644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis in adults with intellectual disabilities.
    Petrone LR
    South Med J; 2012 Feb; 105(2):87-92. PubMed ID: 22267097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National health surveillance of adults with disabilities, adults with intellectual and developmental disabilities, and adults with no disabilities.
    Havercamp SM; Scott HM
    Disabil Health J; 2015 Apr; 8(2):165-72. PubMed ID: 25595297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of the least frail adults with intellectual disabilities: a positive biology perspective.
    Schoufour JD; van Wijngaarden J; Mitnitski A; Rockwood K; Evenhuis HM; Echteld MA
    Res Dev Disabil; 2014 Jan; 35(1):127-36. PubMed ID: 24252590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodevelopmental outcomes of twins.
    Lorenz JM
    Semin Perinatol; 2012 Jun; 36(3):201-12. PubMed ID: 22713502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics in neurodevelopmental disability.
    Racine E; Bell E; Shevell M
    Handb Clin Neurol; 2013; 118():243-63. PubMed ID: 24182383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality of People with Intellectual and Developmental Disabilities from Select US State Disability Service Systems and Medical Claims Data.
    Lauer E; McCallion P
    J Appl Res Intellect Disabil; 2015 Sep; 28(5):394-405. PubMed ID: 25994364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multiple-source method for studying the prevalence of developmental disabilities in children: the Metropolitan Atlanta Developmental Disabilities Study.
    Yeargin-Allsopp M; Murphy CC; Oakley GP; Sikes RK
    Pediatrics; 1992 Apr; 89(4 Pt 1):624-30. PubMed ID: 1372970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of postcensal versus intercensal population estimates on prevalence of selected developmental disabilities--metropolitan Atlanta, Georgia, 1991-1996.
    Lazarus C; Autry A; Baio J; Avchen RN; Van Naarden Braun K
    Am J Ment Retard; 2007 Nov; 112(6):462-6. PubMed ID: 17963437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which neurodevelopmental disorders get researched and why?
    Bishop DV
    PLoS One; 2010 Nov; 5(11):e15112. PubMed ID: 21152085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopmental outcome after extreme prematurity: a review of the literature.
    Jarjour IT
    Pediatr Neurol; 2015 Feb; 52(2):143-52. PubMed ID: 25497122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between older persons with down syndrome and a control group: clinical characteristics, functional status and sensorimotor function.
    Carmeli E; Kessel S; Bar-Chad S; Merrick J
    Downs Syndr Res Pract; 2004 Jun; 9(1):17-24. PubMed ID: 15332436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of secondary medical problems, impairments, and participation limitations among adults with disabilities and their relationship to health and other outcomes.
    Kinne S
    Disabil Health J; 2008 Jan; 1(1):42-50. PubMed ID: 21122710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the prevalence of autism spectrum disorder, cerebral palsy, hearing loss, intellectual disability, and vision impairment, metropolitan atlanta, 1991-2010.
    Van Naarden Braun K; Christensen D; Doernberg N; Schieve L; Rice C; Wiggins L; Schendel D; Yeargin-Allsopp M
    PLoS One; 2015; 10(4):e0124120. PubMed ID: 25923140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The co-occurrence of autism and birth defects: prevalence and risk in a population-based cohort.
    Schendel DE; Autry A; Wines R; Moore C
    Dev Med Child Neurol; 2009 Oct; 51(10):779-86. PubMed ID: 19416313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis.
    Giannini MJ; Bergmark B; Kreshover S; Elias E; Plummer C; O'Keefe E
    Disabil Health J; 2010 Apr; 3(2):74-8. PubMed ID: 21122771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term care of the aging population with intellectual and developmental disabilities.
    Kim NH; Hoyek GE; Chau D
    Clin Geriatr Med; 2011 May; 27(2):291-300. PubMed ID: 21641512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.